Published in Oncology Business Week, March 29th, 2009
Earlier this year, NRH sought a new method for urinary output monitoring and management to comply with the new Medicare regulation CMS1533. The mandate, made effective Oct. 1, 2008, states that hospitals will no longer be reimbursed for treatment of catheter-associated urinary tract infections developed during a patient's stay. After a successful four-week product trial, Liberty was proven to meet NRH's goals...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.